MedPath

HAMAD MEDICAL CORPORATION

πŸ‡ΆπŸ‡¦Qatar
Ownership
-
Established
1979-01-01
Employees
-
Market Cap
-
Website
https://www.hamad.qa

Gastroenteritis in Pediatric Population of Qatar

Recruiting
Conditions
Gastroenteritis
First Posted Date
2017-02-08
Last Posted Date
2024-03-22
Lead Sponsor
Hamad Medical Corporation
Target Recruit Count
3000
Registration Number
NCT03046342
Locations
πŸ‡ΆπŸ‡¦

Hamad medical corporation, Doha, Qatar

Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis

Phase 3
Terminated
Conditions
Thalassemia Majors (Beta-Thalassemia Major)
Osteoporosis
Interventions
Drug: Zoledronic Acid 5Mg/Bag 100Ml Inj
First Posted Date
2017-02-02
Last Posted Date
2019-12-12
Lead Sponsor
Hamad Medical Corporation
Target Recruit Count
17
Registration Number
NCT03040765
Locations
πŸ‡ΆπŸ‡¦

National Center for Cancer Care & Research (NCCCR), Doha, Qatar

Stress Induced Hyperglycemia In Trauma

Completed
Conditions
Stress Induced Hyperglycemia
Trauma
Diabetes Mellitus
First Posted Date
2016-12-21
Last Posted Date
2020-07-23
Lead Sponsor
Hamad Medical Corporation
Target Recruit Count
300
Registration Number
NCT02999386
Locations
πŸ‡ΆπŸ‡¦

Hamad Medical Coorporation, Doha, Qatar

Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures

Phase 4
Completed
Conditions
Seizures
Interventions
First Posted Date
2016-09-13
Last Posted Date
2019-07-24
Lead Sponsor
Hamad Medical Corporation
Target Recruit Count
150
Registration Number
NCT02897856
Locations
πŸ‡ΆπŸ‡¦

Hamad medical corporation, Doha, Qatar

Management of Tunneled Catheter Thrombosis in Hemodialysis Patients: Prospective Study From Qatar

Phase 4
Completed
Conditions
Hemodialysis, Tunneled Catheter, Qatar
Interventions
Drug: (TauroLock Hep500)
Drug: TauroLock U 25000
First Posted Date
2016-08-16
Last Posted Date
2016-08-16
Lead Sponsor
Hamad Medical Corporation
Target Recruit Count
170
Registration Number
NCT02868697
Locations
πŸ‡ΆπŸ‡¦

Fahd Bin Jassem Dialysis Centre, Doha, Qatar

PROspective Study to OPTimize thE HEALTH of Patients With TIAs (Transient Ischemic Attacks) and Stroke Admitted to the Hamad General Hospital

Not Applicable
Conditions
Transient Ischemic Attack (TIA)
Stroke
Interventions
Other: Aggressive Management
First Posted Date
2016-08-16
Last Posted Date
2018-09-06
Lead Sponsor
Hamad Medical Corporation
Target Recruit Count
400
Registration Number
NCT02868723
Locations
πŸ‡ΆπŸ‡¦

Hamad Medical Corporation, Doha, Qatar

Nurse Graduateness and Patient Outcomes: a Cross Sectional Pilot Study

Conditions
no Spedific Condition, All-cause In-patient Mortality
First Posted Date
2016-03-10
Last Posted Date
2016-03-11
Lead Sponsor
Hamad Medical Corporation
Target Recruit Count
1252
Registration Number
NCT02705001

Pharyngitis,Group A Streptococcal Infection,Rapid Streptococcal Test,Throat Swab Culture

Not Applicable
Completed
Conditions
Pharyngitis
Interventions
Procedure: Rapid Immunochromatographic streptococcal test
First Posted Date
2015-07-10
Last Posted Date
2015-07-10
Lead Sponsor
Hamad Medical Corporation
Target Recruit Count
906
Registration Number
NCT02494219
Locations
πŸ‡ΆπŸ‡¦

Hamad medical corporation, Doha, Qatar

Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting

Phase 1
Completed
Conditions
Gastroenteritis
First Posted Date
2015-06-17
Last Posted Date
2015-06-17
Lead Sponsor
Hamad Medical Corporation
Target Recruit Count
40
Registration Number
NCT02473887

Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.

Phase 3
Recruiting
Conditions
Bronchial Asthma
Interventions
Drug: Hi-dose iv MgSO4
Drug: Std-dose iv MgSO4
Drug: Nebulized normal saline
First Posted Date
2015-05-28
Last Posted Date
2024-03-22
Lead Sponsor
Hamad Medical Corporation
Target Recruit Count
240
Registration Number
NCT02455687
Locations
πŸ‡ΆπŸ‡¦

Hamad Medical Corporation, Doha, Qatar

Β© Copyright 2025. All Rights Reserved by MedPath